Petros Pharmaceuticals Statistics
Total Valuation
PTPI has a market cap or net worth of 294,699. The enterprise value is -4.84 million.
| Market Cap | 294,699 |
| Enterprise Value | -4.84M |
Important Dates
The last earnings date was Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTPI has 42.37 million shares outstanding. The number of shares has increased by 8,641.96% in one year.
| Current Share Class | 42.37M |
| Shares Outstanding | 42.37M |
| Shares Change (YoY) | +8,641.96% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 8.73% |
| Owned by Institutions (%) | 0.17% |
| Float | 36.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.10 |
| P/TBV Ratio | 0.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.11 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25
| Current Ratio | 2.25 |
| Quick Ratio | 2.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -36.72% |
| Return on Invested Capital (ROIC) | -207.98% |
| Return on Capital Employed (ROCE) | -161.67% |
| Weighted Average Cost of Capital (WACC) | 13.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.43M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.31% in the last 52 weeks. The beta is 1.66, so PTPI's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -99.31% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 55.73 |
| Average Volume (20 Days) | 123,757 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.64M |
| Pretax Income | -4.50M |
| Net Income | -43.69M |
| EBITDA | -1.81M |
| EBIT | -4.64M |
| Earnings Per Share (EPS) | -1.56 |
Balance Sheet
The company has 5.14 million in cash and n/a in debt, with a net cash position of 5.14 million or 0.12 per share.
| Cash & Cash Equivalents | 5.14M |
| Total Debt | n/a |
| Net Cash | 5.14M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 2.87M |
| Book Value Per Share | 0.07 |
| Working Capital | 2.87M |
Cash Flow
| Operating Cash Flow | -6.73M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.83M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PTPI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8,641.96% |
| Shareholder Yield | -8,641.96% |
| Earnings Yield | -14,825.03% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 1, 2025. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 1, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |